Celularity Inc 8-K

What Happened

• On January 16, 2026, Celularity Inc.'s Compensation Committee approved a First Amendment to the Amended and Restated Employment Agreement for John Haines, the company's Senior Executive Vice President, Global Manager and Chief Administrative Officer. The change was disclosed in an 8-K filed January 21, 2026 under Item 5.02.

Key Details

• Severance period increased to 24 months (previously 12 months).
• COBRA (continuation of health coverage) payment extended to 18 months.
• Equity options that would have vested over the 24-month period after termination will vest immediately upon termination.
• Amendment approved by the Compensation Committee on January 16, 2026.

Why It Matters

• The amendment increases the company’s contractual post-termination obligations for this executive, potentially raising cash or expense obligations if termination occurs.
• Immediate vesting of the specified options removes the future forfeiture condition for that 24-month tranche, accelerating potential equity dilution for shareholders if those options are exercised.
• Investors should note this executive compensation change as part of corporate governance and cost considerations; the filing reports the amendment but does not disclose any termination event or payment made.